Zacks Research Has Weak Outlook for Henry Schein Q1 Earnings

Henry Schein, Inc. (NASDAQ:HSIC) – Research analysts at Zacks Research decreased their Q1 2025 earnings estimates for Henry Schein in a note issued to investors on Tuesday, March 18th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $1.11 per share for the quarter, down from their prior estimate of $1.17. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Zacks Research also issued estimates for Henry Schein’s Q2 2025 earnings at $1.21 EPS, Q3 2025 earnings at $1.26 EPS, Q4 2025 earnings at $1.26 EPS, FY2025 earnings at $4.84 EPS, Q1 2026 earnings at $1.32 EPS, Q2 2026 earnings at $1.36 EPS, Q3 2026 earnings at $1.25 EPS, Q4 2026 earnings at $1.39 EPS, FY2026 earnings at $5.31 EPS and FY2027 earnings at $5.74 EPS.

Other equities research analysts have also recently issued reports about the company. Wells Fargo & Company started coverage on Henry Schein in a research note on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price target for the company. Jefferies Financial Group lifted their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and upped their price target for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Barrington Research reiterated an “outperform” rating and set a $90.00 price objective on shares of Henry Schein in a research note on Wednesday, February 26th. Finally, UBS Group cut their target price on Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 26th. Six analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $81.10.

Henry Schein Stock Down 1.6 %

Henry Schein stock opened at $70.84 on Thursday. Henry Schein has a 1-year low of $63.67 and a 1-year high of $82.49. The business has a fifty day moving average price of $74.84 and a 200-day moving average price of $72.62. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The stock has a market capitalization of $8.80 billion, a price-to-earnings ratio of 29.15, a PEG ratio of 2.13 and a beta of 0.90.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). The firm had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company’s revenue was up 5.8% compared to the same quarter last year. During the same quarter last year, the firm earned $0.66 EPS.

Hedge Funds Weigh In On Henry Schein

Institutional investors and hedge funds have recently modified their holdings of the stock. Versant Capital Management Inc raised its position in Henry Schein by 274.6% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after acquiring an additional 335 shares in the last quarter. Investment Management Corp VA ADV acquired a new stake in shares of Henry Schein during the 4th quarter worth approximately $32,000. Venturi Wealth Management LLC increased its holdings in shares of Henry Schein by 3,347.1% during the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock valued at $41,000 after purchasing an additional 569 shares in the last quarter. Quent Capital LLC lifted its stake in shares of Henry Schein by 91.2% in the 4th quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after purchasing an additional 323 shares during the period. Finally, Smartleaf Asset Management LLC boosted its holdings in Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock worth $52,000 after buying an additional 143 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.